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Background: The developmental morphogen sonic hedgehog (Shh) may continue to play a trophic role in the
support of terminally-differentiated motor neurons, of potential relevance to motor neuron disease. In addition, it
may support the proliferation and differentiation of endogenous stem cells along motor neuronal lineages. As such,
we have examined the trophic and proliferative effects of Shh supplementation or Shh antagonism in embryonic
spinal cord cell cultures derived from wildtype or G93A SOD1 mice, a mouse model of amyotrophic lateral sclerosis.
Results: Shh supported survival, and stimulated growth of motor neurons, neurite outgrowth, and neurosphere
formation in primary culture derived from both G93A SOD1 and WT mice. Shh increased the percentage of ciliated
motor neurons, especially in G93A SOD1 culture. Shh-treated cultures showed increased neuronal proliferation
compared to controls and especially cyclopamine treated cultures, from G93A SOD1 and WT mice. Moreover, Shh
enhanced cell survival and differentiation of motor neuron precursors in WT culture.
Conclusions: Shh is neurotrophic to motor neurons and has mitogenic effects in WT and mSOD1 G93A culture
in vitro.
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The role of sonic hedgehog (Shh) in the patterning of
embryonic motor neurons is well established [1-4], as is
a role for Shh in the maintenance of stem cell populations
in the adult [5,6]. The importance of Shh in terminally-
differentiated neurons is less studied. Nonetheless, Shh
signaling remains active in these cells, and Shh signaling
may be of importance in adult neurodegenerative dis-
eases including Parkinson’s disease [7-11], chronic dia-
betic neuropathy [12], and amyotrophic lateral sclerosis
(ALS) [13].
With respect to ALS, we have shown [13] that Shh has
trophic effects in cultured N2A cells transfected with
plasmids expressing either human wildtype (WT) or
G93A SOD1 (mSOD), a mutated human SOD1 respon-
sible for some familial ALS. Canonical Shh signaling oc-
curs through the primary cilium, and we have shown* Correspondence: turnbull@mcmaster.ca
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reproduction in any medium, provided the or[14] that primary cilia are reduced in cell culture and in
motor neurons in situ in the spinal cord of transgenic
mSOD mice, possibly contributing to a reduction in Shh
signaling in these cells.
The major clinical deficit in ALS results from the dys-
function and death of motor neurons, and therapeutic
manipulation of the Shh pathway could be trophic to
dying motor neurons and reduce this death. In principle,
Shh could also act as a proliferative agent leading to the
expansion of endogenous motor neuron progenitors and
their subsequent differentiation into motor neurons, ser-
ving to replace dying motor neurons. Our previous ex-
periments were undertaken in N2A cells, which are
immortalized cells derived from mouse neuroblastoma,
and not suited to the study of Shh-induced differenti-
ation. As such, we have undertaken the following experi-
ments in primary mixed cultures from spinal cord of
embryonic WT or mSOD mice to determine the trophic
and proliferative effects of Shh augmentation, or antag-
onism with cyclopamine.. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Ma et al. BMC Neuroscience 2013, 14:119 Page 2 of 9
http://www.biomedcentral.com/1471-2202/14/119We demonstrate here that Shh has trophic activity en-
couraging neurite outgrowth and prolonging survival of
spinal motor neurons derived from WT and mSOD
mice, and as well, proliferative activity increasing stem




All breeding and animal experiments were approved by
the McMaster University Animal Research Ethics Board
and were carried out in accordance with guidelines of
the National Institutes of Health and the Canadian Coun-
cil on Animal Care. Six to eight week old male mSOD
mice were mated with eight to ten week old female B6SJL
mice purchased from Jackson Laboratories. We checked
daily for a vaginal plug, and considered embryonic age as
E 0.5 days when one was first seen. At E 13.5 days the
dams were euthanized and embryonic spinal cords dis-
sected. Embryo tails were genotyped for the mSOD trans-
gene using the PCR protocol outlined on the Jackson
Laboratories website.
Primary cell culture
Primary mixed cultures enriched for motor neurons
were undertaken as previously described [14,15]. Embry-
onic spinal cords were carefully dissected under micros-
copy and were processed individually. The isolated
spinal cords with meninges removed were cut into small
pieces and dissociated in 1% trypsin (Sigma) for 15 mi-
nutes. After trypsinization, an equal volume of trypsin
inhibitor (Sigma) was added and the mixture was lightly
triturated until a single cell suspension was achieved.
The cell suspension was then transferred to neurobasal
medium containing 1% glutamax (Invitrogen) and centri-
fuged at 400 g for 5 minutes without brake. The super-
natant was discarded and the cell pellet resuspended in
complete neurobasal medium containing 1% glutamax, 3%
horse serum, 1× B-27 supplement (all from Invitrogen),
5 ng/ml ciliary neurotrophic factor (CNTF) and 5 ng/ml
brain-derived neurotrophic factor (BDNF) (Leinco). 2.5 or
5 × 104 cells per well were plated onto poly-D-lysine
(Sigma) coated 8-well chamber slides (Labtek) and grown
in a 37°C incubator in 5% CO2 environment. Unless other-
wise specified, half of the culture volume was replaced
with fresh medium every the third day.
Shh and cyclopamine administration
At day 2 in culture (d2), either recombinant human Shh
protein (Leinco) or cyclopamine (Sigma) was added to
complete neurobasal medium. Cells grown in complete
neurobasal medium served as controls. The recombinant
Shh protein encompassed amino acids Cys24-Gly197 of
the N-terminal portion with Ile-Ile substituted for Cys24,and was resuspended in distilled H2O without any carrier
protein. Stock solutions of cyclopamine were diluted in
pure dimethyl sulfoxide (DMSO). Even though the final
amount of DMSO added to the cultures was minuscule,
we initially carried DMSO controls. There was no effect
of the DMSO, and normal controls (without Shh or
cyclopamine) were subsequently carried as above.
Motor neuron survival assay
To study the effect of Shh or cyclopamine on motor
neuron survival, 2.5 × 104 cells per well from 2 embryos
of WT mice were plated. At d2, Shh (250 ng/ml) or
cyclopamine (12.5 μM) was added to cell culture medium.
The medium was replaced every 2 days containing Shh or
cyclopamine until d11. At d11, the cell cultures were
processed for immunofluorescent staining with the neuro-
filament heavy antibody (SMI32), a marker of motor neu-
rons. The number of SMI32+ cells per well was counted
under widefield deconvolution microscopy (Leica DMI
6000 B, Germany) at 20× magnification. 7–8 fields were
counted and counts averaged.
Assessment of motor neurons and motor neuron ciliation
In this experiment, 2 embryos from WT mice and 2
from mSOD mice were used. With each embryo, 5 × 104
cells per well were plated onto poly-D-lysine coated 8-
well chamber slides. At d2 of culture, the cells were
treated with Shh (0, 250, 500 ng/ml) for 10 days. Half of
the culture volume was replaced every third day. At d11,
the cell medium were removed, fixed with 4% parafor-
maldehyde (PFA), and processed for immunofluorescent
staining to determine the percentage of motor neurons
and motor neuron ciliation. Adenylyl cyclase type 3
(ACIII) was used as a marker of primary cilia, while
SMI32 was used to label motor neurons. Motor neuron
numbers were estimated by counting SMI32+ cells, and
motor neuron percentages calculated relative to DAPI
stained nuclei. Motor neuron ciliation was assessed as
the percentage of SMI32+ cells staining with ACIII.
BrdU (bromodeoxyuridine) labeling for cell proliferation,
cell survival, and cell differentiation
Cell proliferation was determined by BrdU (Sigma) in-
corporation. 5 × 104 cells per well were plated onto poly-
D-lysine coated 8-well chamber slides. At d2 of culture,
the cells were treated with Shh (250 ng/ml for G93A SOD
mice or 500 ng/ml for WT mice) or cyclopamine (5 μM
for G93A SOD mice or 10 μM WT mice) for 10 days. Half
of the culture volume was replaced every third day. At
d11, 5 μM BrdU was added to the medium. For cell pro-
liferation assays, cells were incubated with BrdU for
24 hours, after which the cell medium was removed, fixed
with 4% PFA, and processed for immunofluorescent stain-
ing to determine the percentage or number of BrdU
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cells were incubated with BrdU for 72 hours and then
BrdU was removed. The cells were continued in medium
containing Shh (500 ng/ml) till d26. The cells were then
fixed with 4% PFA prior to immunofluorescent staining
for BrdU, oligodendrocyte transcription factor 2 (Olig2),
homeobox gene Hb9 (Hb9), and SMI32.
Immunofluorescent staining for primary cilia, motor
neurons, and BrdU labeling cells
At the indicated time points, cells were fixed with 4%
PFA at room temperature for 10 minutes, after which
cells were washed twice with PBS (phosphate buffer so-
lution). For detection of BrdU labeled cells, cells were
pre-treated with deionized formamide for 2 h at 65°C,
2 N HCl for 30 min at 37°C, and 3% normal goat serum
(Vector Laboratories) for 30 min at room temperature.
For all other staining, cells were permeabilized with
methanol for 10 minutes at −20°C. Fixed permeabilized
cells were blocked with 5% goat serum (Invitrogen)/0.3%
Triton X-100 (Sigma) in PBS for 1 hour at room tempe-
rature. All cells were then incubated with primary anti-
bodies overnight at 4°C. Primary antibodies include rabbit
anti-ACIII (1:1000, Santa Cruz Biotechnology), rat anti-
BrdU (1:200, Serotec, Martinsried, Germany), mouse anti-
nestin monoclonal antibody (1:200, Millipore), mouse
anti-SMI32 (1:1000, Abcam), mouse anti-Olig2 polyclonal
antibody (1:200, Millipore), rabbit anti-SMI32 (1:200,
Abcam), rabbit anti-mouse Gli3 (1:200, Abcam), chicken
anti-mouse glial fibrillary acidic protein (GFAP) (1:200,
Millipore). The next day, cells were rinsed in PBS and
then incubated with secondary antibodies for 4 h at 4°C.
Secondary antibodies include Alexa Fluor 488 goat anti-
rat antibody (1:500), Alexa Fluor 568 goat anti-mouse
highly cross-adsorbed antibody (1:500), and Alexa Fluor
647 goat anti-chicken antibody (1:500) (all from Molecular
Probes, Carlsbad, USA). Then cells were rinsed several
times and mounted on slides and coverslipped with Pro-
Long anti-fade with DAPI (Molecular Probes, Carlsbad,
USA) and examined by widefield deconvolution micros-
copy (Leica DMI 6000 B).
Cilial and cell counting
100 SMI32+ cells per treatment, an equal number from
each embryo, were randomly selected to count ciliated
motor neurons at 63× magnification. Only cells separate
enough to be easily distinguished one from another were
selected. For BrdU labeled proliferating cells, 8 to 11
random fields were captured during one session with
constant camera settings (Hamamatsu Orca ER-A) at
20× magnification. For BrdU labeled surviving and dif-
ferentiating cells, 15 random fields containing BrdU la-
beled cells were imaged at 63× magnification. (Higher
magnification was used for the chronic studies since someof the BrdU label was diluted due to cell divisions, and
was easier seen at higher power). Images were converted
to TIFF files by using image analysis software (Image J).
Single, double or triple labeling cells were counted by
using LSM5 image browser (Carl Zeiss).
Statistical analysis
A one-way analysis of variance (ANOVA) (Statistica, ver-
sion 6.0, StatSoft, Tulsa, OK) was used to determine sig-
nificant differences. When there was significant difference,
Newman-Keuls significant difference test was used post-
hoc. Unless otherwise noted, all data are presented as
means ± standard error of the mean (SEM). Significant
differences were defined as p ≤ 0.05, two tailed.
Results
The effect of Shh modulation on motor neurons in
culture
In canonical Shh signaling, Shh action is transduced by
the downstream DNA-binding Gli proteins. To assess
the efficacy of experimental modulation of Shh signaling
in these mixed embryonic spinal cord cultures from WT
and mSOD mice, we added Shh or cyclopamine to the
culture media and stained for Gli3 at d2 till d11. As
expected, for both WT and mSOD cultures, Gli3 stain-
ing was increased in Shh treated cultures and reduced in
cyclopamine-treated cultures. When co-stained with
SMI32 or GFAP (a marker of astrocytes), all SMI32 la-
beled cells stained for Gli3 (Figure 1A), suggesting that
the Shh pathway is active in mature motor neurons ex-
pressing phosphorylated neurofilaments. In contradis-
tinction, no GFAP-positive cells in culture expressed
Gli3 (Figure 1B). We conclude that Shh is bioactive in
primary motor neurons in culture and this activity may
be modulated by addition of Shh or cyclopamine.
Shh has trophic effects on motor neurons
We then focused on the effects of Shh or cyclopamine on
motor neuron morphology and number. We treated WT
and mSOD cultures with Shh (250 or 500 ng/ml) or
cyclopamine (5 μM or 10 μM) between d2 and d10 and
then examined SMI32 staining. At this time in culture,
SMI32+ cells had long, ramified processes that stained
intensely. Groups of positive cells were also present in
neurospheres. Cultures treated with Shh 250 or 500 ng/ml
had greatly increased SMI32 staining compared to control
and especially compared to cells treated with cyclopamine.
This is illustrated in Figure 2 where SMI32 staining in cells
treated with Shh 250 ng/ml (Figure 2A) are compared
with those treated with cyclopamine 5 μM (Figure 2B).
Shh-treated cells had larger somata and more arborization,
while in cyclopamine-treated but not Shh-treated cultures,
dying cells were seen. TUNEL staining confirmed these
cells were dying from apoptosis (not shown).
BA
Gli3 SMI32/GFAP DAPI Merged
GFAP
SMI32
Figure 1 The effect of Shh on Gli3 expression of motor neurons in culture. After treated with Shh, every single SMI32+ cells co-stained with
Gli3 (A), but none of GFAP+ cells was found to co-stain with Gli3+ (B). Scale bar = 10 μm (A, B).
Ma et al. BMC Neuroscience 2013, 14:119 Page 4 of 9
http://www.biomedcentral.com/1471-2202/14/119To quantity the effect of the Shh pathway on motor
neuron survival, cells from WT and mSOD mice were
treated between d2 and d10 with control medium or
media containing Shh 250 ng/ml or cyclopamine 12.5 μM.
We counted the total number of SMI32+ cells in 7–8 ran-
dom low power (X 20) fields, and the results are reported
as both the average number SMI32+ cells per low power
field, and as the percentage SMI32+ cells relative to total
cells present (DAPI). Cultures in control media averaged
5 ± 0 SMI32+ cells per low power field, while Shh had
11 ± 1 and cyclopamine 3 ± 0. The differences in theseA shh
SMI32/DAPI S
C
Figure 2 Shh has trophic effects on motor neurons. Representative mic
250 ng/ml had larger somata and more arborization (A) compared to cyclo
SMI32+ cells per field after treated with 250 ng/ml Shh was significantly hi
** p = 0.0001; Shh 11 ± 1 vs cyclopamine 3 ± 0, * p = 0.0001; cyclopaminecounts are highly significant as shown in Figure 2C.
When compared as a percentage of total cells, similar
results were seen (Figure 3C). Thus, repeated adminis-
tration of Shh to mixed neuronal cultures increases the
percentage and absolute number of motor neurons.
The effect of Shh on motor neurons and motor neuron
ciliation
Canonical Shh signaling occurs through the primary
cilium. We have previously shown that primary cilia are
present in cultured motor neurons and they are reducedB cyclopamine
MI32/DAPI
roscopic images show SMI32+ cells from WT mice treated with Shh
pamine-treated cells (B). It was shown that the average number of
gher than that control and cyclopamine (Shh 11 ± 1 vs control 5 ± 0,



















































































Figure 3 The effect of Shh on motor neurons and motor
neuron ciliation. Representative microscopic images show there
were more SMI32+ cells (green) co-stained with a cilial marker ACIII
(red) in Shh 250 ng/ml treated cell culture (B) than in control culture
(A) from mSOD mice. In WT cells, both doses of Shh significantly
increased the percentage of motor neurons in culture and
significantly increased the percentage of ciliated motor neurons
(C- note the different y axes). A similar situation occurred in the
mSOD cells (C). * p<0.001, Shh (250 ng/ml and 500 ng/ml) vs
control (0) for motor neuron percentage and ciliated motor neuron
percentage in both WT and G93A SOD1 mice.
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[14]. We investigated whether repeated doses of Shh
(250, 500 ng/ml) added to the culture media from d2 to
d10 could enhance the percentage of ciliated motor neu-
rons. At d11 cells were stained for SMI32 and the cilial
marker ACIII (Figure 3A, 3B).
In WT cells, both doses of Shh significantly increased
the percentage of motor neurons in culture, consistent
with the above results, and significantly increased the
percentage of ciliated motor neurons (Figure 3C- note
the different y axes). A similar situation occurred in the
mSOD cells, though if anything the effect on ciliation
was more pronounced. We conclude that Shh treatment
at either dose (both were roughly equivalent) increased
the number of ciliated motor neurons in culture, and es-
pecially so for mSOD cells.
The mitogenic effect of Shh on cell proliferation
Shh might increase the number of motor neurons by re-
ducing motor neuron death or by increasing neuronal
progenitor proliferation and differentiation into motorneurons. The previous experiments are too short to
examine stem cell differentiation into mature (SMI32+)
motor neurons (which might take 30–40 days), and the
increase seen is due to reduced motor neuron death.
However, analysis of BrdU staining at short and longer
time frames would allow examination of the additional
processes of neuronal progenitor proliferation and differ-
entiation down motor neuron pathways.
We first examined the effect of Shh modulation on cell
proliferation by examining BrdU incorporation into cells
in culture 24 hours after a single dose of BrdU (Figure 4).
There was a robust effect of Shh in both WT and mSOD
cultures (Figure 4A, 4B, 4C). The effect of cyclopamine
was absent or relatively subdued. When quantified, Shh
treated WT (Figure 4D, 4F) and mSOD (Figure 4E, 4G)
cultures had a significantly higher percentage or number
of BrdU+ cells than control or cyclopamine treated cul-
tures. We conclude that Shh treatment increases cell
proliferation in both WT and mSOD cultures.
We next examined the effect of Shh modulation on
neuronal progenitor proliferation by examining BrdU+
cells staining for Nestin, an intermediate filament pro-
tein and neuronal progenitor marker, 24 hours after a
single dose of BrdU (Figure 4). The effects of Shh but
not cyclopamine in both WT and mSOD cultures were
obvious (Figure 4A, 4B, 4C). When quantified, Shh
treated WT (Figure 4H, 4J) and mSOD (Figure 4I, 4K)
cultures had a significantly higher percentage and number
of double-labeled BrdU+/nestin+ cells than cyclopamine
treated cultures or control cultures (Figure 4H, 4I, 4J, 4K).
We conclude that Shh treatment increases proliferation of
neuronal progenitor cells in both WTand mSOD cultures.
The effect of Shh on cell survival and differentiation
Neuronal progenitors differentiate and mature into motor
neurons, during which they express a progression of
markers [16]. Commonly employed markers include
(in order) Islet1, Olig2, Hb9, and SMI32. We first exam-
ined the effect of Shh on cell survival in WT culture by
counting BrdU labeled cells 2 weeks after BrdU was re-
moved (Figure 5A, 5B). Shh administration led to a signifi-
cant increase in the number of BrdU+ cells (Figure 5D).
The effect was seen mainly for cell counts rather than per-
centage of total cells, Figure 5C.
We stained for Islet1 and Olig2, but we formally counted
only Olig2, further downstream from Islet1. As expected,
far fewer (BrdU+/Olig2+) double-labeled cells were de-
tected (Figure 5A, 5B). Both the percentage and the num-
ber of cells double-labeled with Olig2 and BrdU was
significantly higher in Shh treated cultures than in controls
(Shh 39.2% ± 4.6% vs control 17.0% ± 3.0%, p = 0.0003;
Shh 5 ± 1 vs control 2 ± 0, p = 0.0001, Figure 5E, 5F).
We also examined Hb9, but at the time point we chose,
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Figure 4 (See legend on next page.)
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Figure 4 The mitogenic effect of Shh on cell proliferation. Representative microscopic images show BrdU labeled proliferating cells (green),
nestin labeled neuronal cells (red), and doubling labeled proliferating neuronal cells of BrdU and nestin in the control (A), 250 ng/ml shh treated
(B), and 5 μM cyclopamine treated (C) cell cultures from mSOD mice. With overall cell proliferation (D, E, F, G), shh treated cell culture from both
WT (C, E) and mSOD mice (D, F) had a significantly higher percentage (D, E) or number of BrdU+ cells (F, G) than control or cyclopamine treated
cultures. With neuronal cell proliferation (H, I, J, K), shh treated cell culture from both WT (H, J) and mSOD mice (I, K) had a significantly higher
percentage (H, I) or number of double labeling of BrdU+/nestin+ cells (J, K) than control or cyclopamine treated cultures. The effect of cyclopamine
was absent or relatively subdued in G93A SOD1 mice. ** shh vs control, * shh vs cyclopamine, δ cyclopamine vs control Scale bar =25 μm (A, B, C).
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we saw no BrdU+ cells staining for SMI32. This is
expected since previous studies [16,17] estimate that it
takes 12 days for neural stem cells to differentiate into
Olig2+ cells, but 4–5 weeks for them to express Hb9.
We conclude that Shh treatment leads to neuronal pro-







Figure 5 The effect of Shh on cell survival and differentiation. Represe
(green), Olig2 labeled motor neuron precursor cells (red), and doubling la
treated cell culture (B) from WT mice. The number (D) but not percentag
treated cultures than in controls. Both the percentage and the number of c
treated cultures than in controls (Shh 39.2% ± 4.6% vs control 17.0% ± 3.0%, *
Scale bar =10 μm (A, B).neuron lineages, but insufficient time elapsed for us to
see mature motor neurons develop. (It is difficult to
maintain robust motor neurons in mixed spinal cord in
culture for more than a few weeks without antibiotics to
prevent bacterial overgrowth, and motor neurons from




ntative microscopic images show BrdU labeled surviving cells
beled BrdU and Olig2 cells in control (A) and in 500 ng/ml shh
e (C) of BrdU labeled surviving cells was significantly higher in Shh
ells double-labeled with Olig2 and BrdU were significantly higher in Shh
* p = 0.0003; Shh 5 ± 1 vs control 2 ± 0, ** p = 0.0001, E, F).
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We hypothesized that Shh might be trophic to motor
neurons in primary embryonic spinal cord culture, and
over a longer time frame, facilitate the proliferation and
differentiation of stem cells along motor neuronal line-
ages. Evidence supporting both possibilities was seen.
In the short term, Shh reamins biologically active in
terminally-differentiated motor neurons and reduces motor
neuron death relative to other cells, while cyclopamine
increases it. This trophic effect is seen in both WT and
mSOD cultures.
Canonical Shh signaling requires the integrity of the
primary cilium, and the percentage of ciliated motor
neurons increases more so than the percentage of motor
neurons in total, especially in mSOD cultures. This
could be explained if Shh had a trophic effect on cilia, or
perhaps more likely, if there were a preferential retention
of ciliated motor neurons, in which Shh signaling is
more efficient and the trophic effect of Shh greater.
The reduction in motor neuron death suggests that
Shh augmentation could play a therapeutic role in ALS,
where the dysfunction and death of motor neurons are
central. However, the extrapolation of cell death in these
embryonic cultures to the cell death characterizing late
onset neurodegenerative disease must be made with cau-
tion. There is considerable variability in in-vitro systems
and it remains unclear that the processes of cell death in
culture faithfully mirror neurodegenerative cell death.
Nonetheless, it is now clear that Shh signaling remains
active in adult neurons. Shh has been shown to regulate
pre-synaptic terminal size and modulate pre-synaptic
function in cultured hippocampal neurons [18]. Our re-
sults are consistent with previous results demonstrating
a trophic effect of Shh in models of Parkinson’s Disease
[8,10], stroke [19-21], diabetic neuropathy [12,22], and
spinal injury [23-26]. They are consistent with our previ-
ous studies in ALS culture models using N2A cells ex-
posed to oxidative challenge [13]. As such, the Shh
signaling pathway retains interest as a therapeutic target
in neurodegenerative disease.
Shh increases stem cell proliferation in short term cul-
ture and markers of differentiation along motor neuronal
lines in longer term culture. The increase in BrdU/Olig2
double-stained cells may be due to an increase in produc-
tion of Olig2+ cells, a reduction in Olig2+ cell death, or
both. Future studies quantifying cell death might be able
to distinguish between these possibilities. The failure to
see increased markers of mature motor neurons in surviv-
ing cells likely reflects the time needed for full differenti-
ation of motor neurons, which might take 5 weeks or
more in vitro [17]. However, we have found it difficult to
extend the mSOD cultures more than a few weeks. This
may relate to factors related to expression of the mutant
transgene, to an increased sensitivity of these cells toantibiotics, or other factors. Since there is no adequate
way of distinguishing these possibilities, we cultured with-
out antibiotics, and longer term studies were undertaken
only in WTcells.
It has been a long hope that stem cell therapy might
be beneficial in neurodegenerative disease in general and
ALS in particular. Most effort has been placed on deliv-
ery of exogenous stem cells. However, the support and
targeted differentiation of endogenous stem cells might
also be beneficial. In spinal cord injury and stoke, Shh
treatment by a variety of delivery approaches [23-26]
improves functional recovery, an effect mediated, at
least in part, by expansion of oligodendroglial/motor
neuronal precursors [24]. Our results suggest that the
Shh-induced differentiation and maintenance of motor
neuronal precusors occurs in ALS models and may be a
fruitful approach in ALS.
Conclusion
Shh provides trophic support for spinal motor neurons
in primary culture derived from WT and G93A SOD1
mice. Shh also increases production of motor neuronal
progenitor cells in these culture systems. These attributes
could prove useful in therapeutic approaches to adult
motor neuron diseases, and suggest that the Shh pathway
remains an interesting therapeutic target in ALS. Further
studies of Shh in ALS models are warranted.
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